Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1989-8-23
|
pubmed:abstractText |
Human glioblastoma cells secrete an inhibitory factor termed "glioblastoma-derived T-cell suppressor factor" (G-TsF). A member of the transforming growth factor beta (TGF beta) family, G-TsF is identical to TGF beta 2. The present study investigated the effect of G-TsF/TGF beta 2 on the proliferative and cytotoxic properties of tumor-infiltrating lymphocytes (TIL's) isolated from malignant gliomas after expansion in vitro with interleukin-2 (IL-2). The results demonstrate that the IL-2 (5 to 20 U/ml)-dependent proliferative response of glioma-derived TIL's was inhibited 70% to 85% by G-TsF/TGF beta 2 and that the inhibitory effect could be reduced by using increasing concentrations of IL-2 (100 to 200 U/ml). Tumor necrosis factor alpha (TNF alpha) enhanced the IL-2-dependent proliferation of TIL's cultured in low concentrations of IL-2 (10 U/ml); however, neither TNF alpha nor interferon gamma was able to reduce the inhibitory effect of TGF beta 2 on TIL proliferation. In addition, TGF beta 2 suppressed 60% to 100% the cytotoxic response of glioma-derived TIL's against several tumor targets, including autologous glioma cells, and the suppressive effect was shown to be reduced by increasing concentrations of IL-2.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-3085
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
211-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2545842-Brain Neoplasms,
pubmed-meshheading:2545842-Cell Division,
pubmed-meshheading:2545842-Cytotoxicity, Immunologic,
pubmed-meshheading:2545842-Glioblastoma,
pubmed-meshheading:2545842-Humans,
pubmed-meshheading:2545842-Interleukin-2,
pubmed-meshheading:2545842-Peptides,
pubmed-meshheading:2545842-T-Lymphocytes,
pubmed-meshheading:2545842-Transforming Growth Factor beta,
pubmed-meshheading:2545842-Transforming Growth Factors
|
pubmed:year |
1989
|
pubmed:articleTitle |
Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.
|
pubmed:affiliation |
Department of Neurosurgery, Centre Hôpitalier Universitaire Vaudois, Lausanne, University Hospital, Zurich, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|